Concepedia

Savita Bidyasar

SB

Statistics

Publications

5

Citations

188

H-Index

5

Active since

2008

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Savita Bidyasar is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, medicine, and life sciences.

Publications per year

2008–2021

5

Publications

5

Inhibition of the Ras/Raf/MEK/ERK and RET Kinase Pathways with the Combination of the Multikinase Inhibitor Sorafenib and the Farnesyltransferase Inhibitor Tipifarnib in Medullary and Differentiated Thyroid Malignancies

David S. Hong, Maria E. Cabanillas, Jennifer J. Wheler et al. · The Journal of Clinical Endocrinology & Metabolism · 2011 · 110 citations · Full text

Medicine, Oncology, Pharmacology +17

Sweet Syndrome Associated With Granulocyte Colony-Stimulating Factor

Savita Bidyasar, Maria E. Montoya, Kausar Suleman et al. · Journal of Clinical Oncology · 2008 · 33 citations

Life Sciences, Hematology, Immunology +8

Real-world performance of blood-based proteomic profiling in first-line immunotherapy treatment in advanced stage non-small cell lung cancer

Patricia Rich, R. Brian Mitchell, Eric Schaefer et al. · Journal for ImmunoTherapy of Cancer · 2021 · 22 citations · Full text

Life Sciences, Immunology, Oncology +17

A first-in-human phase I trial of PBI-05204 (oleandrin), an inhibitor of Akt, FGF-2, NF-Kb, and p70S6K in advanced solid tumor patients

Savita Bidyasar, Razelle Kurzrock, G. S. Falchook et al. · Journal of Clinical Oncology · 2009 · 13 citations

Medicine, Pharmacokinetics, Pharmacology +17

Dose-finding study of hepatic arterial infusion of irinotecan-based treatment in patients with advanced cancers metastatic to the liver

Rabih Said, Razelle Kurzrock, Aung Naing et al. · Investigational New Drugs · 2015 · 10 citations

Medicine, Oncology, Pharmacology +17

1–5 of 5